Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications

Moi, Davide
Secondo
;
2021-01-01

Abstract

Since the approval of three hydroxamic acid-based HDAC inhibitors as anticancer drugs, such functional groups acquired even more notoriety in synthetic medicinal chemistry. The ability of hydroxamic acids (HAs) to chelate metal ions makes this moiety an attractive metal binding group-in particular, Fe(III) and Zn(II)-so that HA derivatives find wide applications as metalloenzymes inhibitors. In this minireview, we will discuss the most relevant features concerning hydroxamic acid derivatives. In a first instance, the physicochemical characteristics of HAs will be summarized; then, an exhaustive description of the most relevant methods for the introduction of such moiety into organic substrates and an overview of their uses in medicinal chemistry will be presented.
2021
Inglese
6
34
21843
21849
7
Esperti anonimi
internazionale
scientifica
no
Citarella, Andrea; Moi, Davide; Pinzi, Luca; Bonanni, Davide; Rastelli, Giulio
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
5
open
File in questo prodotto:
File Dimensione Formato  
ACS Omega 2021.pdf

accesso aperto

Descrizione: Articolo principale
Tipologia: versione editoriale
Dimensione 3.44 MB
Formato Adobe PDF
3.44 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie